glp-1 drugs and parkinson's disease Glucagon-like peptide-1 (GLP-1) receptor agonists neuroinflammation: Implications for neurodegenerative treatment Researching GLP-1 drugs and Parkinson's

The medications are revitalizing postpartum health, and an increasing number of women are seeking them out

Together, this multifactorial dilemma stipulates the necessity for the field to investigate novel pharmaceuticals and to extend the therapeutic utility of well-researched drugs already used in clinical practice

Due to the similar molecular mechanism between T2DM and AD, several drugs for the treatment of T2DM are increasingly being proposed for the treatment of AD (15, 82)

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide

GLP-1 receptor agonists: an updated review of head-to-head clinical studies

This pronounced transformation in dietary preferences and spending behaviors is prompting food manufacturers to shift their marketing strategy and adapt their product offerings